Ten-year FFTF after various approaches to treatment of NLPHL
| Stages included . | n . | Treatment . | 10-y FFTF estimate (%) . | Reference . |
|---|---|---|---|---|
| RT studies | ||||
| I–II, A or B | 312 | IFRT or EFRT 48% or RT+ABVD type chemo 52% | ∼75 | 1 |
| IA | 45 | IFRT | 94 | 4 |
| 45 | EFRT | 84 | ||
| IA, IIA | 46 | EFRT | 77 | 5 |
| 35 | IRRT | 83 | ||
| 25 | IFRT | 66 | ||
| IA, IIA | 202 | EFRT 76% | 88 | 6 |
| IFRT 24% | ||||
| RT + chemo studies | ||||
| IA | 41 | RT+ABVD type chemo | 94 | 4 |
| I–II, A or B | 56 | RT+ABVD type chemo 75% or ABVD alone (4 cycles) 25% | 98 | 2 |
| Stages included . | n . | Treatment . | 10-y FFTF estimate (%) . | Reference . |
|---|---|---|---|---|
| RT studies | ||||
| I–II, A or B | 312 | IFRT or EFRT 48% or RT+ABVD type chemo 52% | ∼75 | 1 |
| IA | 45 | IFRT | 94 | 4 |
| 45 | EFRT | 84 | ||
| IA, IIA | 46 | EFRT | 77 | 5 |
| 35 | IRRT | 83 | ||
| 25 | IFRT | 66 | ||
| IA, IIA | 202 | EFRT 76% | 88 | 6 |
| IFRT 24% | ||||
| RT + chemo studies | ||||
| IA | 41 | RT+ABVD type chemo | 94 | 4 |
| I–II, A or B | 56 | RT+ABVD type chemo 75% or ABVD alone (4 cycles) 25% | 98 | 2 |
ABVD type chemo, ABVD, COPP/ABVD, or BEACOPP chemotherapy; EFRT, extended field radiation; IFRT, involved field RT; IRRT, involved region RT; RT, radiation.